If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.50
Bid: 15.00
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 1.00 (6.667%)
Open: 15.50
High: 15.50
Low: 15.50
Prev. Close: 15.50
THRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

H1 Trading Update

12 Oct 2022 07:00

RNS Number : 5427C
Thruvision Group PLC
12 October 2022
 

12 October 2022

 

Thruvision Group plc

 

("Thruvision" or the "Group")

 

H1 Trading Update

 

 

Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market, is pleased to provide an update on trading for the six months ended 30 September 2022.

 

Revenues for the period are expected to be £2.8 million, representing growth of 41% versus the comparable period last year (H1FY22 £2.0 million, H2FY22 £6.4 million). We currently have an order backlog for equipment totalling $8.3 million (£7.5 million at today's rate of $1.11, see below) and expect most, if not all, of this to be delivered to revenue during our second half. Cash as at 30 September 2022 was £1.1 million, and has since grown to stand at £3.1 million as at 11 October 2022.

 

Customs

 

As announced on 22 September and 5 October 2022, we received two strategically important orders from US Customs and Border Protection (CBP), via our US Government contracting partner, totalling $9.7 million. The first of these orders, totalling $2.7 million, was to complete the process of upgrading CBP's existing fleet of 60 cameras to our latest 16-channel camera variant. Half of this first order was delivered in H1 with the balance to be delivered in H2.

 

The second order, for $7.0 million, was the first we received under a new framework purchasing agreement which can, in principle, allow CBP to place additional orders for a further four years up to the end of September 2026. This order further expands the CBP fleet of Thruvision equipment and is expected to broaden operational deployments into major US international airports for the first time. Although anticipated, the order size is larger than we had expected for FY23.

 

Our April 2022 trading update stated that CBP had made public its intentions to acquire significant numbers of additional "passive body scanners" during 2022 and beyond. This framework purchasing agreement provides a mechanism through which CBP can execute this intention. In this context, it is worth noting that in total, Thruvision received orders worth $14.0 million from CBP in the US Government's last financial year (1 Oct 2021 to 30 September 2022).

 

Profit Protection

 

As we stated in our announcement of 22 September 2022, the economic situation has become more challenging for retailers since our April update. This has resulted in our Profit Protection equipment revenues for H1 being unchanged at £1.0 million (H1FY22 £1.0 million), despite the strong overall growth as described above.

 

Encouragingly, existing Profit Protection customers, who now fully appreciate the in-year return on their investment from deploying Thruvision technology, continue to expand and upgrade their Thruvision fleets. In particular, we are seeing strong interest in our latest "walkTHRU" lane which we pioneered with Next PLC, and for which we recently won a retail industry award. The lane uses two cameras and our AI algorithm to significantly increase the throughput rate, allowing 100% employee screening, thereby maximising deterrence and very materially reducing levels of theft.

 

Our focus on Third-Party Logistics providers (3PLs) which operate significant numbers of distribution centres has also delivered further success. In addition to CEVA, we have added a second major global 3PL, which is headquartered in Germany. This customer has placed an initial order for a dual-camera walk-through lane for a high profile site in the UK and we now expect to sign a global supply framework agreement with them. We are also discussing further deployments over the next few months with this customer.

 

Almost all retail organisations we speak to are reporting rising employee theft due, in large part, to the rapidly increasing cost of living. Therefore, we remain confident that a combination of existing customers who understand the return on investment and new retailers / 3PLs, who look to Thruvision's flagship customers, will allow us to maintain, if not grow, this sector over the course of this financial year.

 

Aviation

 

While the broader aviation market is steadily recovering, we saw further significant delays in the US Transportation Security Administration (TSA) accreditation process due to the after effects of COVID-related disruption. We expect accreditation testing to recommence this autumn. Such accreditation would enable the use of our solutions for passenger security screening in US airports. Modest renewed demand from US airports for employee security screening is re-emerging.

 

International

 

Although we received no orders in the period from Asia or the Middle East, we have a number of very good opportunities in play. We are seeing growing interest from a number of international customs agencies and expect to this to develop over the second half of the year in what are, inevitably, longer sales cycles.

 

Outlook

 

The Group is entering a new phase in its development. With the strategically significant purchasing framework now in place with CBP; a material order backlog in place for our second half; and the balance of opportunities we see across our various end markets, we expect to deliver strong growth this financial year.

 

The Board expects that the strong growth we are experiencing will allow us to achieve our objective of breaking even this financial year.

 

 

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425400

Tom Black, Executive Chairman

Colin Evans, Chief Executive

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon / Tom Blundell

 

About Thruvision

Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford, and Washington DC.

 

 

www.thruvision.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZMMGKMZGZZM
Date   Source Headline
21st Feb 20222:07 pmRNSExercise of Sharesave Share Options
25th Jan 20224:06 pmRNSSharesave option grant to Executive Director
24th Dec 20217:00 amRNSDirector Share Dealing
22nd Dec 202112:42 pmRNSHolding(s) in Company
2nd Dec 20216:00 pmRNSDirector Share Dealing
2nd Dec 20212:00 pmRNSInvestor Presentation
1st Dec 202111:36 amRNSDirector Share Dealing
30th Nov 20215:39 pmRNSAward of Share Options to Executive Directors
30th Nov 20211:50 pmRNSDirector Share Dealing
22nd Nov 20217:00 amRNSInterim Results
11th Nov 20217:00 amRNSNotice of Interim Results
27th Oct 20218:52 amRNSBlocklisting application
7th Oct 20217:00 amRNSTrading Update
4th Oct 20219:10 amRNSBlocklisting update
28th Sep 202110:31 amRNSResult of Annual General Meeting
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSDirector Share Dealing
27th Jul 20211:00 pmRNSDirector/PDMR Shareholding
16th Jul 20213:27 pmRNSReplacement: Holding(s) in Company
15th Jul 20214:43 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSResults for the Year ended 31 March 2021
9th Jul 20212:34 pmRNSReplacement: Investor Presentation
9th Jul 202111:00 amRNSInvestor Presentation
5th Jul 202112:00 pmRNSNotice of Results
27th May 20211:24 pmRNSDirector Share Dealing
1st Apr 20217:00 amRNSPre-Close Statement
31st Mar 20213:00 pmRNSBlocklisting update
11th Mar 20215:53 pmRNSHolding(s) in Company
10th Mar 20213:33 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSAppointment of Non-Executive Director
1st Dec 20207:00 amRNSThruvision Investor Presentation
23rd Nov 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSNotice of Interim Results
9th Oct 202010:18 amRNSHolding(s) in Company
7th Oct 20207:00 amRNSPre-close Trading Update
22nd Sep 202010:31 amRNSResult of Annual General Meeting
18th Sep 20207:00 amRNSContract award announcement
26th Jun 202010:32 amRNSHolding(s) in Company
23rd Jun 20205:21 pmRNSHolding(s) in Company
22nd Jun 20204:24 pmRNSHolding(s) in Company
17th Jun 202011:05 amRNSSecond Price Monitoring Extn
17th Jun 202011:01 amRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSAward of Share Options to Executive Directors
8th Jun 20207:00 amRNSResults for the Year ended 31 March 2020
3rd Jun 20207:22 amRNSNotice of Annual Results
3rd Jun 20207:00 amRNSNotice of Annual Results
2nd Apr 20207:40 amRNSTrading Statement
25th Nov 20197:00 amRNSInterim Results
19th Nov 20197:00 amRNSNotice of Interim Results
13th Nov 20193:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.